Source: Eur Respir J 2016; 47: 751-768
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Essat Munira, Harnan Sue, Gomersall Tim, Tappenden Paul, Wong Ruth, Pavord Ian, Lawson Rod, Everard Mark L.. Fractional exhaled nitric oxide for the management of asthma in adults: a systematic review. Eur Respir J 2016; 47: 751-768

Member's Comments

No comment yet.

Related content which might interest you: Fractional exhaled nitric oxide in preterm-born subjects: A systematic review and meta-analysis. Source: International Congress 2019 – Neonatal and paediatric intensive care Year: 2019 Predictive value of exhaled nitric oxide in the management of asthma: a systematic review Source: Eur Respir J 2016; 48: 706-714 Year: 2016 Clinical utility of fractional exhaled nitric oxide in severe asthma management Source: Eur Respir J, 55 (3) 1901633; 10.1183/13993003.01633-2019 Year: 2020 Fractional exhaled nitric oxide (FeNO) for an early diagnosis of asthma Source: Eur Respir J 2006; 28: Suppl. 50, 677s Year: 2006 Fractional exhaled nitric oxide is associated with more severe asthma Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children Source: Eur Respir J 2003; 21: 433-438 Year: 2003 Fractional exhaled nitric oxide (FeNO) in asthmatic children and their parents Source: Eur Respir J 2006; 28: Suppl. 50, 270s Year: 2006 Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) to monitor asthma control Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients Source: Eur Respir J 2008; 31: 539-546 Year: 2008 Investigation on the effectiveness of the Mostgraph and fractional exhaled nitric oxide measurement in chronic cough Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Exhaled nitric oxide (FeNO) levels to guide treatment for adults with asthma: A Cochrane systematic review Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD Source: Breathe, 15 (4) 306; 10.1183/20734735.0268-2019 Year: 2019 Exhaled nitric oxide in childhood asthma: methodological issues and clinical applications Source: Eur Respir Rev 2006; 15: 215-217 Year: 2006 Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Exhaled nitric oxide (eNO) for an epidemiological study in adults Source: Eur Respir J 2005; 26: Suppl. 49, 281s Year: 2005 Economic evaluation of fractional exhaled nitric oxide (FENO) for the management of adult asthma in Spain Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Clinical usefulness of fractional exhaled nitric oxide (FeNO) as a marker of long-term asthma control Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 Diagnosing asthma using exhaled nitric oxide (eNO) measurements Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma Year: 2003 Fractional exhaled nitric oxide in bronchiectasis Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Improvement of asthma control assessed by exhaled nitric oxide: a real-life longitudinal study Source: Eur Respir J 2005; 26: Suppl. 49, 276s Year: 2005